Medical Writing
Medical Writing
Pubblicazioni recenti

  1. Effect of pioglitazone on cardiac sympathovagal modulation in patients with type 2 diabetes.
    Gianiorio FE, Casu M, Patrone V, Egan CG, Murialdo G. Acta Diabetol. 2011 Feb 11. [Epub ahead of print]
  2. Role of the fixed-dose combination lercanidipine-enalapril in renal protection.
    Egan CG, Pontremoli R. J Nephrol. 2011 Jan 24. pii: D1BB2E59-9E72-4123-B90C-0F8EC72A2A76. [Epub ahead of print]
  3. Bioavailability of Sandimmun® versus Sandimmun Neoral®: a meta-analysis of published studies.
    Colombo D, Egan CG. Int J Immunopathol Pharmacol. 2010 Oct-Dec;23(4):1177-83.
  4. Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients.
    Egan CG, Caporali F, Capecchi PL, Lazzerini PE, Pasini FL, Sorrentino V. Heart Vessels. 2010 Oct 30. [Epub ahead of print]
  5. Mucoactive drugs.
    Balsamo R, Lanata L, Egan CG. Eur Respir Rev. 2010 Jun 1;19(116):127-33. Review.
  6. Use of isoxsuprine hydrochloride as a tocolytic agent in the treatment of preterm labour: a systematic review of previous literature.
    Giorgino FL, Egan CG. Arzneimittelforschung. 2010;60(7):415-20.
  7. Reduced levels of putative endothelial progenitor and CXCR4+ cells in coronary artery disease: kinetics following percutaneous coronary intervention and association with clinical characteristics.
    Egan CG, Caporali F, Huqi AF, Zito MC, Focardi M, Mondillo S, Pierli C, Marzilli M, Sorrentino V. Thromb Haemost. 2009 Jun;101(6):1138-46.
  8. Endothelial progenitor cells and colony-forming units in rheumatoid arthritis: association with clinical characteristics.
    Egan CG, Caporali F, Garcia-Gonzalez E, Galeazzi M, Sorrentino V. Rheumatology (Oxford). 2008 Oct;47(10):1484-8. Epub 2008 Aug 5.
  9. Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes.
    Egan CG, Lavery R, Caporali F, Fondelli C, Laghi-Pasini F, Dotta F, Sorrentino V. Diabetologia. 2008 Jul;51(7):1296-305. Epub 2008 Feb 20.
  10. Differentiation of hippocampal stem cells into functional neurons: evolving our understanding of monoamine oxidase-A inhibition.
    Egan CG. Br J Pharmacol. 2006 Jul;148(5):563-4. Epub 2006 May 15.
  11. PDGF-induced signaling in proliferating and differentiated vascular smooth muscle: effects of altered intracellular Ca2+ regulation.
    Egan CG, Wainwright CL, Wadsworth RM, Nixon GF. Cardiovasc Res. 2005 Aug 1;67(2):308-16.
  12. Endothelin-1- and depolarization-induced differential regulation of cAMP response element-binding protein in proliferating and developed vascular smooth muscle.
    Egan CG, Nixon GF. Cell Signal. 2004 Dec;16(12):1387-96.
  13. Pathophysiology of vascular dysfunction in a rat model of chronic joint inflammation.
    Egan CG, Lockhart JC, Ferrell WR. J Physiol. 2004 Jun 1;557(Pt 2):635-43. Epub 2004 Apr 2.
  14. Pathophysiological basis of acute inflammatory hyperaemia in the rat knee: roles of cyclo-oxygenase-1 and -2.
    Egan CG, Lockhart JC, Ferrell WR, Day SM, McLean JS. J Physiol. 2002 Mar 1;539(Pt 2):579-87.
  15. Expression of constitutive but not inducible cyclooxygenase maintains articular perfusion in the rat knee.
    Egan CG, Lockhart JC, McLean JS, Ferrell WR. Exp Physiol. 2001 Mar;86(2):191-7.
  16. Metacarpophalangeal joints in rheumatoid arthritis: laser Doppler imaging--initial experience.
    Ferrell WR, Balint PV, Egan CG, Lockhart JC, Sturrock RD. Radiology. 2001 Jul;220(1):257-62.
Aula didattica Primula Editore
it
en